Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs is a research paper published in Health Economics (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: R01AG054424
Australian Research Council
Grant: FT200100630
ARC Future Fellowships - Grant ID: FT200100630
National Institutes of Health
Grant: 5R01AG054424-03
Impact of Medicare Part D Gap Closure on Health Outcomes
FWCI
0.85
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals